Cytosorbents (CTSO) Total Debt (2016 - 2026)
Cytosorbents (CTSO) posted Total Debt of $17.0 million for Q1 2026, up 1.75% on a QoQ basis from $16.7 million in Q4 2025, and up 19.54% year-over-year from $14.2 million in Q1 2025.
Cytosorbents (CTSO) Total Debt (2016 - 2026) Analysis & Trends
Cytosorbents' Total Debt history runs 10 years deep, the most recent figure standing at $17.0 million for Q1 2026.
- Quarterly Total Debt rose 19.54% year-over-year to $17.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $17.0 million (up 19.54% YoY) and the FY2025 annual result came in at $16.7 million, up 19.08% from the prior year.
- Total Debt was $17.0 million for Q1 2026 at Cytosorbents, up from $16.7 million in the prior quarter.
- Across five years, Total Debt topped out at $17.0 million in Q1 2026 and bottomed at $4.4 million in Q1 2024.
- A 5-year average of $10.6 million and a median of $13.7 million in 2024 frame the typical range for Total Debt.
- Annual changes were most pronounced in 2024 — Total Debt fell 11.62% — and 2025, when it soared 220.35%.
- Cytosorbents' Total Debt stood at $5.0 million in 2022, then gained by 0.86% to $5.0 million in 2023, then soared by 177.54% to $14.0 million in 2024, then climbed by 19.08% to $16.7 million in 2025, then grew by 1.75% to $17.0 million in 2026.
- Business Quant data shows CTSO's Total Debt at $17.0 million in Q1 2026, $16.7 million in Q4 2025, and $14.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 34.05 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 14.72 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 27.96 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 11.03 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 598.50 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 9.48 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 10.14 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 3.18 Bn |
| 10 | Cytosorbents | 22.58 Mn | 17.78 Mn | 6.13 Mn | 16.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 16.96 Mn |
| Dec 31, 2025 | 16.67 Mn |
| Sep 30, 2025 | 14.57 Mn |
| Jun 30, 2025 | 14.38 Mn |
| Mar 31, 2025 | 14.19 Mn |
| Dec 31, 2024 | 14.00 Mn |
| Sep 30, 2024 | 13.81 Mn |
| Jun 30, 2024 | 13.67 Mn |
| Mar 31, 2024 | 4.43 Mn |
| Dec 31, 2023 | 5.04 Mn |
| Sep 30, 2023 | 5.03 Mn |
| Jun 30, 2023 | 5.02 Mn |
| Mar 31, 2023 | 5.01 Mn |
| Dec 31, 2022 | 5.00 Mn |
| Sep 30, 2020 | 15.16 Mn |
| Jun 30, 2020 | 21.79 Mn |
| Mar 31, 2020 | 15.09 Mn |
| Dec 31, 2019 | 15.05 Mn |
| Sep 30, 2019 | 3.21 Mn |
| Jun 30, 2019 | 9.99 Mn |